Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. [electronic resource]
- Journal of the American College of Cardiology Jun 2011
- 19-25 p. digital